Roflumilast

Roflumilast | CAS NO: 162401-32-3 , Roflumilast is a PDE4 inhibitor used to reduce severe Chronic Obstructive Pulmonary Disease (COPD) exacerbations, specifically chronic bronchitis, and as a topical treatment for plaque psoriasis, seborrheic dermatitis, and atopic dermatitis. Oral tablets, often branded as Daliresp, reduce inflammation and open airways, while topical forms manage skin inflammation. 

We are the Synchemia Research Chemical specializes in manufacturing and supplying of Roflumilast  impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities.  Roflumilast is a PDE4 inhibitor used to reduce severe Chronic Obstructive Pulmonary Disease (COPD) exacerbations, specifically chronic bronchitis, and as a topical treatment for plaque psoriasis, seborrheic dermatitis, and atopic dermatitis. Oral tablets, often branded as Daliresp, reduce inflammation and open airways, while topical forms manage skin inflammation.  Buy Reliable and High-Purity Roflumilast Impurities, Delivered by Synchemia Research Chemicals.